Logo for Innate Pharma S.A.

Innate Pharma Investor Relations Material

Latest events

Logo for Innate Pharma S.A.

Study Result

Innate Pharma
Logo for Innate Pharma

Study Result

12 Dec, 2023
Logo for Innate Pharma

Q3 2023

14 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications. It generates its products from the expression platforms based on its phage display and dAb technologies. The company's lead product is NexoBrid, which is a treatment for severe burns that can be used outside of the European Union; and Phase 3 NExoBrid clinical trial is completed in Europe.  Innate Pharma S.A. was founded in 2000 as Innate ImmunoPharmaceuticals S.A.; and it changed its name to Innate Pharma S.A. in 2011. Innate Pharma S.A. has operations in Saint Prex, Switzerland; and Sophia Antipolis, France. Innate Pharma S.A is based in Marseille, France.